CINECA IRIS Institutional Research Information System

DANESI, ROMANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 46.019
AS - Asia 16.402
EU - Europa 13.933
SA - Sud America 2.834
AF - Africa 684
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 19
AN - Antartide 1
Totale 79.949
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 44.872
CN - Cina 5.180
IT - Italia 4.446
HK - Hong Kong 3.760
SG - Singapore 3.754
BR - Brasile 2.441
SE - Svezia 2.364
DE - Germania 1.510
BG - Bulgaria 1.381
GB - Regno Unito 981
VN - Vietnam 945
CA - Canada 903
TR - Turchia 882
RU - Federazione Russa 656
UA - Ucraina 632
FI - Finlandia 612
KR - Corea 504
IN - India 347
CI - Costa d'Avorio 259
FR - Francia 238
CH - Svizzera 224
JP - Giappone 195
AT - Austria 176
BD - Bangladesh 152
AR - Argentina 140
BE - Belgio 120
NL - Olanda 114
MX - Messico 110
GR - Grecia 102
PL - Polonia 96
ZA - Sudafrica 96
ID - Indonesia 90
SN - Senegal 75
SA - Arabia Saudita 72
IQ - Iraq 67
NG - Nigeria 66
PK - Pakistan 66
ES - Italia 64
CO - Colombia 56
EC - Ecuador 51
UZ - Uzbekistan 50
AU - Australia 47
VE - Venezuela 40
EG - Egitto 38
PY - Paraguay 37
MA - Marocco 36
AE - Emirati Arabi Uniti 30
TW - Taiwan 30
CZ - Repubblica Ceca 29
IE - Irlanda 29
TT - Trinidad e Tobago 29
CL - Cile 26
IR - Iran 25
MY - Malesia 25
IL - Israele 24
KE - Kenya 23
PH - Filippine 23
NP - Nepal 22
TN - Tunisia 22
JO - Giordania 21
LT - Lituania 21
HU - Ungheria 20
RO - Romania 20
TH - Thailandia 19
DK - Danimarca 16
DO - Repubblica Dominicana 16
UY - Uruguay 16
EU - Europa 15
JM - Giamaica 15
AZ - Azerbaigian 14
BJ - Benin 14
DZ - Algeria 14
BO - Bolivia 13
CR - Costa Rica 13
OM - Oman 13
BB - Barbados 12
KZ - Kazakistan 12
PT - Portogallo 12
LB - Libano 11
PA - Panama 11
PE - Perù 11
RS - Serbia 11
AL - Albania 9
HN - Honduras 9
HR - Croazia 9
BH - Bahrain 8
LK - Sri Lanka 8
NO - Norvegia 8
NZ - Nuova Zelanda 8
PS - Palestinian Territory 8
KG - Kirghizistan 7
SV - El Salvador 7
BY - Bielorussia 6
CG - Congo 6
GH - Ghana 6
AM - Armenia 5
GT - Guatemala 5
KW - Kuwait 5
LU - Lussemburgo 5
LV - Lettonia 5
Totale 79.848
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.733
Ashburn 4.275
Fairfield 4.242
Ann Arbor 4.203
Houston 3.997
Hong Kong 3.726
Chandler 2.444
Santa Clara 2.037
Dallas 1.898
Seattle 1.789
Singapore 1.735
Wilmington 1.510
Cambridge 1.448
Sofia 1.378
Shanghai 1.252
Serra 1.079
Beijing 1.039
Milan 1.015
New York 906
Jacksonville 771
Ottawa 740
Boardman 683
Hefei 639
Princeton 620
Lawrence 562
Izmir 550
Los Angeles 507
Medford 506
Seoul 478
Nanjing 450
Dearborn 361
Des Moines 333
London 284
Abidjan 259
Istanbul 249
Dong Ket 236
The Dalles 236
Columbus 226
San Diego 223
Pisa 217
Buffalo 213
Bern 207
Florence 204
Redondo Beach 201
São Paulo 197
Munich 178
Nanchang 174
Boulder 159
Frankfurt am Main 156
Council Bluffs 152
Ho Chi Minh City 145
Vienna 145
Redwood City 144
Tokyo 139
Falls Church 129
Jüchen 126
Rome 126
Washington 125
Kunming 117
Brussels 110
Hanoi 92
Ogden 90
Bremen 89
Hebei 86
Düsseldorf 82
Rio de Janeiro 82
Changsha 77
Chicago 77
Shenyang 77
Belo Horizonte 76
Dakar 75
Warsaw 75
Turku 74
Lagos 65
Norwalk 65
Pune 64
Jiaxing 57
Tianjin 55
Nuremberg 53
Phoenix 52
Fuzhou 50
Toronto 49
Guangzhou 48
Brasília 45
Helsinki 45
Tashkent 45
Dhaka 44
Johannesburg 41
Stockholm 40
Turin 40
Jakarta 39
San Francisco 39
Nürnberg 36
Auburn Hills 35
Jinan 35
Montreal 35
Brooklyn 34
Lancaster 34
Marseille 34
Seacroft 34
Totale 60.248
Salva come PNG Salva come JPEG
Nome #
Pharmacogenomics in non-small-cell lung cancer chemotherapy 608
Mathematical modeling of drug resistance due to KRAS mutation in colorectal cancer 425
A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity 337
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC 302
Exogenous doxorubicinol induces cardiotoxic effects in rats 274
Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab. 272
Synthesis of Novel 3,5-Disubstituted-2-oxindole Derivatives As Antitumor Agents against Human Nonsmall Cell Lung Cancer 270
Procedimento attuato per mezzo di un elaboratore per la determinazione dei tempi di ritenzione e dei valori di concentrazione di analiti in una miscela 262
A rapid high-performance liquid chromatography method to measure linezolid and daptomycin concentrations in human plasma 260
Determination of mitotane and principal metabolite by a simple HPLC-UV method and its validation in human plasma sample 244
Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1. 237
VEGF-A polymorphisms predict short-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration 235
A new validated HPLC-UV method for therapeutic monitoring of daptomycin in comparison with reference LC-MS/MS 231
Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers 226
A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients. 221
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 216
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients 215
Gender, MGMT methylation, and levetiracetam plasma levels correlate with survival benefit in glioblastoma patients treated with adjuvant temozolomide: results from a non-interventional retrospective clinical study 215
ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients. 213
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine 212
First-line metronomic chemotherapy in a metastatic model of spontaneous canine tumours: a pilot study 212
Variable correlation between 6-mercaptopurine metabolites in erythrocytes and hematologic toxicity: implications for drug monitoring in children with acute lymphoblastic leukemia 212
Suramin, a novel antitumor compound 206
In vitro studies on gemcitabine combinations with other antiblastics 206
Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer 206
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer. 206
ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients 204
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 203
EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan 202
Fructose-1,6-diphosphate reduces acute ECG changes due to doxorubicin in isolated rat heart 200
Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer 199
A new validated HPLC-UV method for therapeutic monitoring of daptomycin in comparison with reference Mass Spectrometry 199
Pharmacogenetics in Oncology 198
Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients 198
Association of KRAS mutations in cell-free circulating tumor DNA with occurrence of resistance to TKIs in NSCLC 196
The effect of rhGM-CSF on the proliferation of osteogenic sarcoma cells 195
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia 195
Protein kinase inhibitors for the treatment of advanced and progressive radiorefractory thyroid tumors: From the clinical trials to the real life 195
A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer 193
The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors 193
Effects of Amiodarone, Thyroid Hormones and CYP2C9 and VKORC1 Polymorphisms on Warfarin Metabolism: A Review of the Literature. 193
Population pharmacokinetic analysis of 5-FU and 5-FDHU in colorectal cancer patients: search for biomarkers associated with gastro-intestinal toxicity 192
Doxorubicin cardiotoxicity in the dog: A morphofunctional study 191
A pilot study of suramin in the treatment of metastatic renal cell carcinoma 191
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 191
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 191
General and cardiac toxicity of adriamycinol in rats 190
Pharmacogenomics of gemcitabine in non-small-cell lung cancer and other solid tumors 190
5-Fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer 190
4'-Epidoxorubicin cardiotoxicity 189
Carbogen and nicotinamide combined with unconventional radiotherapy in glioblastoma multiforme: a new modality treatment 189
Periodontal tissue disposition of azithromycin 188
An exploratory study on pharmacogenetics of inosine-monophosphate dehydrogenase II in peripheral mononuclear cells from liver-transplant recipients 188
Cancer stem cell epigenetics and chemoresistance 187
Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration. 187
A selective antimuscarinic agent: pirenzepine. Review of its pharmacologic and clinical properties 185
The effects of the somatostatin analog octreotide on angiogenesis in vitro 185
CYP2D6 polymorphisms and the impact on tamoxifen therapy 185
Chronic administration of suramin induces neurotoxicity in rats 185
The rs2071559 AA VEGFR-2 genotype frequency is significantly lower in neovascular age-related macular degeneration patients. 185
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro 185
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA 185
Doxorubicin modifies plasma levels of immunoreactive atrial natriuretic factor 184
Impact of locoregional approaches to liver metastases in patients with colorectal cancer 184
Methods: For studying pharmacogenetic profiles of combination chemotherapeutic drugs 181
Molecular basis of resistance to azole antifungals. 180
Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients 180
Pharmacokinetics, a main actor in a many-sided approach to severe 5-FU toxicity prediction 179
The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization 179
Antimicrobial peptides: therapeutic potential for the treatment of Candida infections. 179
The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia. 179
Polycomb genes are associated with response to imatinib in chronic myeloid leukemia 179
Pharmacokinetics and tolerance of nicotinamide combined with radiation therapy in patients with glioblastoma multiforme 178
Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer. 178
Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy 178
Determination of mitotane and metabolite by a simple HPLC-UV method and application in plasma samples 177
Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine 177
Embryonic stem cell pathways and chemotherapy response: an unexplored route. 176
Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer 176
5-Fluorouracil exposure in adjuvant chemotherapy regimens is significantly related to disease free survival in colorectal cancer patients 175
Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxel 175
Phosphonomethylphosphorylmethyl(oxy)-analogues of geranylgeranyl diphosphate as stable and selective geranylgeranyl protein transferase inhibitors 175
Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma. 175
An aromatase polymorphism (g.132810C>T) predicts risk of bisphosphonate-related osteonecrosis of the jaw 174
Oral and intravenously administered mTOR inhibitors for metastatic renal cell carcinoma: pharmacokinetic considerations and clinical implications 174
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients 174
Appropriateness of repetitive therapeutic drug monitoring and laboratory turn around time 174
Synergistic cytotoxicity, inhibition of signal transduction pathways and pharmacogenetics of sorafenib and gemcitabine in human NSCLC cell lines 172
Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines 172
Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer 172
Changes of specific atrial granules induced by doxorubicin in dog's heart 171
Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane 171
Intravenous azidothymidine with fluorouracil and leucovorin: a phase I-II study in previously untreated metastatic colorectal cancer patients 171
ROXITHROMYCIN PENETRATION INTO GINGIVA AND ALVEOLAR BONE OF ODONTOIATRIC PATIENTS 171
Synthesis of stable analogues of geranylgeranyl diphosphate possessing a (Z,E,E)-geranylgeranyl side chain, docking analysis, and biological assays for prenyl protein transferase inhibition 171
Efficacy and safety of basiliximab in kidney transplantation 171
An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma. 171
ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview 171
Lung tissue penetration and plasma pharmacokinetics of azithromycin after multiple oral doses of 500 and 1000 mg in adults 170
Time-dependent Pharmacokinetics of 5-fluorouracil and association with treatment tolerability in the adjuvant setting of colorectal cancer 170
Totale 20.299
Salva come PNG Salva come JPEG
Categoria #
all - tutte 226.579
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 226.579
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.751 0 0 0 0 542 252 335 612 506 438 333 733
2021/20226.446 150 395 247 391 1.027 1.006 228 332 262 244 347 1.817
2022/20237.336 1.005 840 474 693 833 1.022 61 565 1.253 48 478 64
2023/20245.397 658 583 710 326 747 1.031 150 263 91 111 183 544
2024/202517.549 112 680 122 965 1.702 1.795 1.332 1.063 1.794 2.287 1.962 3.735
2025/20268.928 1.228 2.950 2.339 1.717 694 0 0 0 0 0 0 0
Totale 81.066